CD79A and nasopharyngeal carcinoma: Therefore, we conducted the present epidemiological study in 1701 NPC patients without treatment from Guangdong province, trying to identify potential environmental risk factors related to VCA‐IgA, EA‐IgA and EBV DNase‐specific neutralizing antibody.